BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 36263581)

  • 1. The impact of sarcopenia on survival and treatment tolerance in patients with head and neck cancer treated with chemoradiotherapy.
    Bentahila R; Giraud P; Decazes P; Kreps S; Nay P; Chatain A; Fabiano E; Durdux C
    Cancer Med; 2023 Feb; 12(4):4170-4183. PubMed ID: 36263581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of sarcopenia on survival and late toxicity in head and neck cancer patients treated with radiotherapy.
    van Rijn-Dekker MI; van den Bosch L; van den Hoek JGM; Bijl HP; van Aken ESM; van der Hoorn A; Oosting SF; Halmos GB; Witjes MJH; van der Laan HP; Langendijk JA; Steenbakkers RJHM
    Radiother Oncol; 2020 Jun; 147():103-110. PubMed ID: 32251949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of sarcopenia as a prognostic biomarker in locally advanced head and neck squamous cell carcinoma.
    Erul E; Guven DC; Ozbay Y; Altunbulak AY; Kahvecioglu A; Ercan F; Yesil MF; Ucdal MT; Cengiz M; Yazici G; Kuscu O; Suslu N; Gullu I; Onur MR; Aksoy S
    Biomark Med; 2023 Jan; 17(2):87-99. PubMed ID: 37042459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of sarcopenia in locally advanced head and neck cancer treated with chemoradiation: An Indian tertiary care hospital experience.
    Nagpal P; Pruthi DS; Pandey M; Yadav A; Singh H
    Oral Oncol; 2021 Oct; 121():105483. PubMed ID: 34403887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The ability of post-chemoradiotherapy DWI ADC
    Connor S; Sit C; Anjari M; Lei M; Guerrero-Urbano T; Szyszko T; Cook G; Bassett P; Goh V
    J Cancer Res Clin Oncol; 2021 Aug; 147(8):2323-2336. PubMed ID: 34159420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlations between DW-MRI and
    Connor S; Sit C; Anjari M; Szyszko T; Dunn J; Pai I; Cook G; Goh V
    Cancer Rep (Hoboken); 2021 Aug; 4(4):e1360. PubMed ID: 33960739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of sarcopenia on tolerance of radiation and outcome in patients with head and neck cancer receiving chemoradiation.
    Ganju RG; Morse R; Hoover A; TenNapel M; Lominska CE
    Radiother Oncol; 2019 Aug; 137():117-124. PubMed ID: 31085391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of maximum standardized uptake value measured by pretreatment 18F-FDG PET/CT in locally advanced head and neck squamous cell carcinoma.
    Cacicedo J; Fernandez I; Del Hoyo O; Navarro A; Gomez-Iturriaga A; Pijoan JI; Martinez-Indart L; Escudero J; Gomez-Suarez J; de Zarate RO; Perez JF; Bilbao P; Rades D
    Clin Transl Oncol; 2017 Nov; 19(11):1337-1349. PubMed ID: 28540535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sarcopenia with inflammation as a predictor of survival in patients with head and neck cancer.
    Yamahara K; Mizukoshi A; Lee K; Ikegami S
    Auris Nasus Larynx; 2021 Oct; 48(5):1013-1022. PubMed ID: 33883097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low Skeletal Muscle Mass Is a Risk Factor for Aspiration Pneumonia During Chemoradiotherapy.
    Endo K; Ueno T; Hirai N; Komori T; Nakanishi Y; Kondo S; Wakisaka N; Yoshizaki T
    Laryngoscope; 2021 May; 131(5):E1524-E1529. PubMed ID: 33030229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of body composition on recurrence and survival of advanced-stage head and neck cancer.
    Jung AR; Roh JL; Kim JS; Kim SB; Choi SH; Nam SY; Kim SY
    Eur J Cancer; 2019 Jul; 116():98-106. PubMed ID: 31185387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of Diffusion-Weighted Imaging and
    Noij DP; Martens RM; Koopman T; Hoekstra OS; Comans EFI; Zwezerijnen B; de Bree R; de Graaf P; Castelijns JA
    Clin Oncol (R Coll Radiol); 2018 Dec; 30(12):780-792. PubMed ID: 30318343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thoracic skeletal muscle index is effective for CT-defined sarcopenia evaluation in patients with head and neck cancer.
    Vangelov B; Smee R; Moses D; Bauer J
    Eur Arch Otorhinolaryngol; 2023 Dec; 280(12):5583-5594. PubMed ID: 37573279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nutritional status and skeletal muscle status in patients with head and neck cancer: Impact on outcomes.
    Findlay M; White K; Brown C; Bauer JD
    J Cachexia Sarcopenia Muscle; 2021 Dec; 12(6):2187-2198. PubMed ID: 34676673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypoxia with 18F-fluoroerythronitroimidazole integrated positron emission tomography and computed tomography (18F-FETNIM PET/CT) in locoregionally advanced head and neck cancer: Hypoxia changes during chemoradiotherapy and impact on clinical outcome.
    Hu M; Xie P; Lee NY; Li M; Ho F; Lian M; Zhao S; Yang G; Fu Z; Zheng J; Ma L; Yu J
    Medicine (Baltimore); 2019 Oct; 98(40):e17067. PubMed ID: 31577699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of sarcopenia on acute radiation-induced toxicity in head and neck cancer patients.
    Karavolia E; van Rijn-Dekker MI; Van den Bosch L; van den Hoek JGM; Oldehinkel E; Meijer TWH; Halmos GB; Witjes MJH; Oosting SF; van der Hoorn A; Langendijk JA; Steenbakkers RJHM
    Radiother Oncol; 2022 May; 170():122-128. PubMed ID: 35304862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival outcomes for head and neck cancer patients with N3 cervical nodal metastases.
    Virk JS; Ingle M; Podesta CM; Gujral DM; Awad Z
    Clin Otolaryngol; 2020 May; 45(3):342-349. PubMed ID: 31869000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of PET/CT with (18)F-fluoroazomycin arabinoside for patients with head and neck squamous cell carcinomas receiving chemoradiotherapy.
    Saga T; Inubushi M; Koizumi M; Yoshikawa K; Zhang MR; Obata T; Tanimoto K; Harada R; Uno T; Fujibayashi Y
    Ann Nucl Med; 2016 Apr; 30(3):217-24. PubMed ID: 26662072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Impact of Skeletal Muscle Depletion on Head and Neck Squamous Cell Carcinoma.
    Nishikawa D; Hanai N; Suzuki H; Koide Y; Beppu S; Hasegawa Y
    ORL J Otorhinolaryngol Relat Spec; 2018; 80(1):1-9. PubMed ID: 29393251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of sarcopenia and myosteatosis on survival outcomes for patients with head and neck cancer undergoing curative-intent treatment.
    Ahern E; Brown TE; Campbell L; Hughes BGM; Banks M; Lin CY; Kenny LM; Bauer J
    Br J Nutr; 2023 Feb; 129(3):406-415. PubMed ID: 35152926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.